Phase I study of LHC165 ± spartalizumab (PDR001) in patients (pts) with advanced solid tumors.

被引：0
|
作者：
Curigliano, Giuseppe [1 ,2 ]
Martin Jimenez, Miguel [3 ]
Shimizu, Toshio [4 ]
Keam, Bhumsuk [5 ]
Meric-Bernstam, Funda [6 ]
Rutten, Annemie [7 ]
Glaspy, John [8 ]
Parikh, Nehal S. [9 ]
Ising, Mary [9 ]
Hassounah, Nadia [9 ]
Wu, Jincheng [9 ]
Xu, Kun [10 ]
Choudhry, Somesh [10 ]
Garralda, Elena [11 ]
机构：
[1] Inst Europeo Oncol IRCCS, Milan, Italy
[2] Univ Milan, Milan, Italy
[3] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[4] Natl Canc Ctr, Tokyo, Japan
[5] Seoul Natl Univ Hosp, Seoul, South Korea
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Sint Augustinus Hosp, Antwerp, Belgium
[8] Univ Calif Los Angeles, Los Angeles, CA USA
[9] Novartis Inst Biomed Res NIBR, Cambridge, MA USA
[10] Novartis Pharmaceut, E Hanover, NJ USA
[11] Hosp Valle De Hebron, Barcelona, Spain
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT103
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
  • [34] Phase I study of sequential sapacitabine and seliciclib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kwak, Eunice Lee
    Cleary, James M.
    Tolaney, Sara
    Gandhi, Leena
    Clark, Jeffrey W.
    Wolanski, Andrew
    Frame, Sheelagh
    Rodig, Scott J.
    Chiao, Judy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Phase I trial of patupilone (P) and RAD001 in patients (pts) with advanced solid tumors
    Stein, M. N.
    Knox, B.
    Wesolowsky, E.
    Levitt, M.
    Moss, R.
    Poplin, E.
    Mehnert, J.
    Gounder, M.
    Goodin, S.
    DiPaola, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] A phase I study of ARQ 197 in combination with temsirolimus in patients (Pts) with advanced stolid tumors.
    Braden, Amy M.
    Wisinski, Kari Braun
    Eickhoff, Jane C.
    Schelman, William R.
    Bailey, Howard Harry
    Mulkerin, Daniel
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Phase I study of weekly oral docetaxel (ModraDoc001) plus ritonavir in patients with advanced solid tumors.
    Marchetti, Serena
    Stuurman, Frederik
    Koolen, Stijn
    Moes, Johannes
    Hendrikx, Jeroen
    Thijssen, Bas
    Huitema, Alwin D. R.
    Nuijen, Bastiaan
    Rosing, Hilde
    Keessen, Marianne
    Voest, Emile E.
    Mergui-Roelvink, M.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 Plus Imatinib for Advanced Treatment-Refractory Gastrointestinal Stromal Tumors
    Kim, Hyung-Don
    Ryu, Min-Hee
    Park, Young Soo
    Yoo, Changhoon
    Kim, Sung-Joo
    Kang, Yoon-Koo
    CLINICAL CANCER RESEARCH, 2024, 30 (13) : 2743 - 2750
12345